Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Richard Im"'
Publikováno v:
ACS Omega, Vol 9, Iss 34, Pp 36086-36098 (2024)
Externí odkaz:
https://doaj.org/article/9fdf65325b2942a39668524e795fde3b
Autor:
Sahra Pajenda, Daniela Gerges, Ludwig Wagner, David O’Connell, Monika Aiad, Richard Imre, Karl Mechtler, Alexander Zimprich, Alice Schmidt, Guerkan Sengoelge, Wolfgang Winnicki
Publikováno v:
Diagnostics, Vol 14, Iss 15, p 1591 (2024)
Primary focal segmental glomerulosclerosis (FSGS) is a disease of the podocytes and glomerulus, leading to nephrotic syndrome and progressive loss of renal function. One of the most serious aspects is its recurrence of disease in over 30% of patients
Externí odkaz:
https://doaj.org/article/cfa81e91b9c14746acfdf662ace30f74
Publikováno v:
Metabolites, Vol 14, Iss 6, p 339 (2024)
In the original publication [...]
Externí odkaz:
https://doaj.org/article/40d1e6fac29b448ab006434844895f42
Autor:
Andreas Lackner, Michael Müller, Magdalena Gamperl, Delyana Stoeva, Olivia Langmann, Henrieta Papuchova, Elisabeth Roitinger, Gerhard Dürnberger, Richard Imre, Karl Mechtler, Paulina A. Latos
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-20 (2023)
Abstract Placental development relies on coordinated cell fate decisions governed by signalling inputs. However, little is known about how signalling cues are transformed into repressive mechanisms triggering lineage-specific transcriptional signatur
Externí odkaz:
https://doaj.org/article/aee667731d554927bb6a4028cee4ef03
Autor:
Cristhian Camilo Rivera-Caldon, Richard Imbachi-Imbachi, Juan Camilo Tobar-Solarte, Rosa Amalia Dueñas-Cuellar
Publikováno v:
Revista de la Facultad de Ciencias de la Salud, Vol 24, Iss 2, Pp 15-23 (2022)
El uso indiscriminado de antibióticos ha generado un grave problema en la salud pública debido al aumento en la resistencia bacteriana. La producción por algunos gérmenes de betalactamasas tipo AmpC forma parte de los mecanismos de resistencia ba
Externí odkaz:
https://doaj.org/article/bb6fba9ef3114e9b9bb1dbb719582fdb
Autor:
Harriet E. O. Cant, Iro Chatzidaki, Birgitta Olsson, Mattias Rudebeck, Jean‐Baptiste Arnoux, Richard Imrich, Lucy A. Eddowes, Lakshminarayan R. Ranganath
Publikováno v:
JIMD Reports, Vol 63, Iss 4, Pp 361-370 (2022)
Abstract Alkaptonuria (AKU) is a rare genetic disorder where oxidised homogentisic acid accumulates in connective tissues, leading to multisystem disease. The clinical evaluation Alkaptonuria Severity Score Index (cAKUSSI) is a composite score that a
Externí odkaz:
https://doaj.org/article/bd9d7265c2564712ae3e74349d93a2bd
Autor:
Lakshminarayan R. Ranganath, Anna M. Milan, Andrew T. Hughes, Milad Khedr, Brendan P. Norman, Mohammed Alsbou, Richard Imrich, Matthew Gornall, Nicolas Sireau, James A. Gallagher, Richard Jackson
Publikováno v:
JIMD Reports, Vol 63, Iss 1, Pp 80-92 (2022)
Abstract Background Outcomes from studies employing nitisinone 10 mg and 2 mg in alkaptonuria were compared. Patients and methods Sixty‐nine patients in each of the nitisinone (10 mg daily) and controls of suitability of nitisinone in alkaptonuria
Externí odkaz:
https://doaj.org/article/5d36e4859dd84f01a498e92ebccc7fb8
Autor:
Birgitta Olsson, Lakshminarayan Ranganath, Jean‐Baptiste Arnoux, Richard Imrich, Anna Milan, Mattias Rudebeck
Publikováno v:
JIMD Reports, Vol 63, Iss 1, Pp 41-49 (2022)
Abstract In an open‐label, controlled study of nitisinone in alkaptonuria (SONIA 2), patients were advised to lower dietary protein intake to reduce serum tyrosine (s‐Tyr) levels and the risk of keratopathy. A body weight increase was observed in
Externí odkaz:
https://doaj.org/article/be3b952aa5464c34a1393c236fa2f965
Autor:
Miroslava Hardonova, Pavel Siarnik, Monika Sivakova, Bianka Sucha, Adela Penesova, Zofia Radikova, Andrea Havranova, Richard Imrich, Miroslav Vlcek, Ingrid Zitnanova, Georgi Krastev, Maria Kiacikova, Branislav Kollar, Peter Turcani
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 13, p 11162 (2023)
Introduction: Epidemiological studies have suggested an increased vascular risk in patients with multiple sclerosis (MS). There is increasing evidence of the beneficial effects of GLP-1 agonists (GLP-1a) in preventing vascular complications and slowi
Externí odkaz:
https://doaj.org/article/be6c860459c34afa8c5fd6e3ef667f1e
Autor:
Lakshminarayan R Ranganath, Milad Khedr, Jean-Baptiste Arnoux, Jozef Rovensky, Richard Jackson, Vanda Mlynarikova, Helen Bygott, Birgitta Olsson, Mattias Rudebeck, Andrea Zatkova, Richard Imrich, Olga Lukacova, Jana Sedlakova, Mária Úlehlová, Matthew Gornall, James Gallagher, Roman Stančík, Eva Vrtíková, Elizabeth Záňová, Emily Luangrath
Publikováno v:
RMD Open, Vol 8, Iss 2 (2022)
Objectives Ochronotic spondyloarthropathy represents one of the main clinical manifestations of alkaptonuria (AKU); however, prospective data and description of the effect of nitisinone treatment are lacking.Methods Patients with AKU aged 25 years or
Externí odkaz:
https://doaj.org/article/7ad17879aed8418c859a209f23af4c38